VIEW SELECTED LIBRARY MEDIA
Name of Media:
NIHR Alert: A newer sedative agent may shorten length of stay in intensive care units
the University of Southampton and Bazian
Publisher or Source:
Type of Media:
Medical Professional Education
Media Originally for:
Critical Care Physicians,General Medical Professionals,Nurses and/or Other Critical Care Medical Professionals
Country of Origin:
United Kingdom of Great Britain and Northern Ireland (the)
Primary Focus of Media:
Pre-Use of PICS Designation
Adults needing mechanical ventilation who were sedated with dexmedetomidine had reduced length of stay in intensive care and reduced duration of ventilation.
Various sedative drugs are available for use in England although it is unclear if one is better than the others. This review compared two alpha-2 agonist drugs (clonidine and dexmedetomidine) to other commonly used sedative drugs: propofol and the benzodiazepines midazolam and lorazepam for adults on mechanical ventilation.
A 2014 survey reported that, while clonidine is used in about a third of units, dexmedetomidine is not frequently used. The latter drug is expensive, and this review did not consider cost-effectiveness which will be an important factor if the drug is to be used more widely.
This review’s findings on dexmedetomidine support best practice guidelines which suggest modest benefits for non-benzodiazepines compared to benzodiazepines.
PostICU, Inc's library staff reviewed this copyrighted material contained in the library and reasonably believes that its inclusion in our library complies with the "Fair Use Doctrine" because: (1) our library's is for nonprofit and educational purposes; (2) the nature of the copyrighted work is related to our mission; (3) the amount and substantiality of the portion used in relation to the copyrighted work as a whole is fair and reasonable; and (4) the potential market for or value of the copyrighted work will if impacted, should be enhanced, by its presence in our library.